Skip to main content

Advertisement

Table 1 Cohort characteristics

From: The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis

Studies Cases (F/C) Mean age (F/C) Male patient (F/C) Dosage (ml) Prophylactic antithrombotic Reference type Quality assessment score
Kim 2012 [11] 97/99 72.7/70.1 NS 10 Aspirin or warfarin, NS RCT 6
Francesco 2013 [9] 51/42 67.9/70.2 24/17 10 LMWH 4,000 IU RCT 4
Suarez 2014 [10] 56/52 65.9/65.1 20/21 10 Enoxaparin, NS RCT 6
Helito 2013 [12] 10/10 67.8/66.6 NS NS Enoxaparin 40 mg PCT 17
Comadoll 2012 [13] 184/165 NS 64/54 20 Warfarin 5 mg CCT 18
  1. F Floseal®, C control, LMWH low molecular weight heparin, NS not stated.